Yaz, Similar Pills Tied To Higher Blood Clot Risks

Law360, New York (April 22, 2011, 5:30 PM EDT) -- Two medical studies published Thursday found that women taking drospirenone-containing birth control pills such as Bayer HealthCare Pharmaceuticals Inc.'s Yasmin and Yaz could be at higher risk of blood clots than those taking oral contraceptives with a different progestin hormone.

The studies in the British Medical Journal, which involved U.S. and U.K. women who used oral contraceptives containing drospirenone or levonorgestrel, come amid a flood of personal injury and wrongful death lawsuits against Bayer over the safety of its popular birth control pills and whether company...
To view the full article, register now.